Sveriges mest populära poddar

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

1 tim 2 min•19 oktober 2023

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.

Fler avsnitt av Hematologic Oncology Update

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

1 apr.•25 min

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

23 mars•24 min

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

21 mars•29 min

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

13 mars•1 tim 3 min

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

11 mars•47 min

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

9 mars•19 min

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

4 mars•24 min

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

18 feb.•58 min

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

13 feb.•17 min

Immune Thrombocytopenia — ASH 2025 Review

6 feb.•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.